New Approach Against Solid Tumors: EU Invests €2.5 Million in Novel Cancer Therapy at TU Dresden
Press/Media
Persons and affiliations
- Anke Fuchs - , Advanced Cellular Therapeutics (Junior Research Group) (Person of interest)
- Michael Sieweke - , Chair of Stem Cell Research with focus on cell-based approaches to regenerative biomedicine (Person of interest)
- TUD Dresden University of Technology